Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00233909
Recruitment Status : Completed
First Posted : October 6, 2005
Last Update Posted : April 1, 2008
Sponsor:
Information provided by:
Kanisa Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2008
Actual Study Completion Date : March 2008